Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy.
about
Biomolecular markers of cancer-associated thromboembolismRisk of venous thromboembolism in patients with cancer: a systematic review and meta-analysisThrombosis: tangled up in NETs.Treatment of advanced Gall bladder cancer in the real world-can continuation chemotherapy improve outcomes?NETosis: a new factor in tumor progression and cancer-associated thrombosisImplementing thrombosis guidelines in cancer patients: a review.Arterial and venous thrombosis in cancer patientsWhite blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø studyPrimary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysisRisk factors for inpatient venous thromboembolism despite thromboprophylaxis.Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohortNeutrophil extracellular trap (NET) impact on deep vein thrombosis.Venous thrombosis and cancer: from mouse models to clinical trials.Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis StudyA Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.Risk assessment models for cancer-associated venous thromboembolism.Predictors of Venous Thromboembolism in Patients with Glioblastoma.Venous thromboembolism in cancer patients: risk assessment, prevention and management.The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.Persistent neutrophilia is a marker for an increased risk of venous thrombosis.Head and neck microvascular free flap reconstruction: An analysis of unplanned readmissions.Retrospective comparison of thromboelastography results to postmortem evidence of thrombosis in critically ill dogs: 39 cases (2005-2010).Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation.Lung Cancer Complicated With Asymptomatic Pulmonary Embolism: Clinical Analysis of 84 Patients.New findings on venous thrombogenesis.[Clinical features in 23 lung cancer patients complicated with pulmonary thromboembolism].
P2860
Q26865716-F02AB4C4-F58E-40C9-A25F-DBB19DEC16FEQ27005043-768142BC-0022-4782-BADE-F824DFF39ABEQ33556910-2154F7DE-828B-4630-B40C-9CA349D52C45Q33593225-25010085-92D9-4342-9D1F-7AC7AA1FB9DFQ33957938-87B9719D-0400-4889-9692-9421AA23F95FQ34463482-A9019053-73B3-4A4D-AEA8-E54C3EFC7D22Q34635182-D4C91B5A-F8EE-4D91-ACAB-0BB951296E60Q34984444-2072ECFA-768F-4BBB-B636-D594AC8D24DDQ35594902-863AE857-3B67-4D77-AB66-421035A9D8A6Q35747987-90FFBFE1-CB29-4005-A1C1-2405254D5AFEQ36277129-9A5480EB-F10F-406C-8751-5D0B2B37FD2DQ36391500-CF4BF219-EF7A-419C-ADF0-82123FB8F4D6Q36636558-44ADD765-4524-4BEA-A292-8AFC5B4FF810Q37060686-FF683FBF-401F-4F5F-9E22-8C8F139F8FE4Q37091111-BD3C9489-18D4-4C44-8F39-B01FBF42F091Q37956590-52DEFB37-0D9F-4686-AF69-32DB9C3C55F4Q38627862-A0D7CA07-953E-4994-9B3D-42932D45F6FAQ38751462-A4A471E0-31E4-4CBD-8FEA-1372EB20E9FEQ39380369-8B921644-358E-4E24-B85F-884C232C4D38Q39627365-8322A227-CAD0-4E18-883B-57A534DA8ABBQ39799355-AB2D0FC5-CA96-4449-B994-3BFFAB8AACBAQ40125387-2FDD0D91-82C6-4D47-83DC-6FF0E1BE36BBQ40217071-A87C9EA7-BB7F-41ED-9584-1F41DA3A47B3Q43854179-9BC62A02-BBD0-4B17-825D-30446088AD38Q46085597-96401046-595A-47E9-91BD-AF966850EDDFQ47156649-EA833268-4DA8-4832-AFA5-5223A3B0F33CQ47385578-B7D08E6F-5C3A-41B4-82E5-E3D4280C8E47Q47657258-9189D446-80E9-46B3-A386-81DD0B6E6474Q47938011-F100CF91-34EF-4486-B090-2AD52B81ADE7Q55443483-648DD82D-6FC3-4DBC-9769-6C5B8046A28A
P2860
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy.
@ast
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy.
@en
type
label
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy.
@ast
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy.
@en
prefLabel
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy.
@ast
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy.
@en
P2093
P2860
P1433
P1476
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy
@en
P2093
Charles W Francis
Eva Culakova
Gary H Lyman
Gregory C Connolly
Nicole M Kuderer
P2860
P304
P356
10.1016/J.THROMRES.2010.05.012
P577
2010-08-01T00:00:00Z